Ann: Appendix 4C - quarterly-AHZ.AX, page-185

Good question poverty boy. There are a whole bunch of aus bio companies with MC round 20-30 million, some with very small revenue and some with no signs of revenue for 3-5 years. Most will require more capital before turning profits. Given ahz have provided path to profitability maybe by 2017 that's what the market was waiting for. And then to have large % increases in profit forecast for following years although not yet proven is the forward looking market thing. I'm hoping now when we get a positive announcement the market with treat it well as they will have an idea of how it will effect future revenues. WP did say partnerships take along time so I hope the VAX one is sorted in the next 12 months in case revenues dont materialize as fast as hoped. I always hoped money would last for that moment and under old management I would have been wrong.